| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 普乐沙福; Plerixafor (AMD3100) | CFN60083 | 110078-46-1 | C28H54N8 = 502.78 | 5mg | QQ客服:3257982914 |
| 达克替尼; Dacomitinib (PF-00299804) | CFN60084 | 1110813-31-4 | C24H25ClFN5O2 = 469.94 | 5mg | QQ客服:1457312923 |
| IWR-1-endo; IWR-1-endo | CFN60085 | 1127442-82-3 | C25H19N3O3 = 409.44 | 5mg | QQ客服:2159513211 |
| CX-5461; CX-5461 | CFN60086 | 1138549-36-6 | C27H27N7O2S = 513.61 | 5mg | QQ客服:1457312923 |
| 卡博替尼苹果酸盐; Cabozantinib malate (XL184) | CFN60087 | 1140909-48-3 | C28H24FN3O5.C4H6O5 = 635.59 | 5mg | QQ客服:1457312923 |
| Capivasertib (AZD5363); Capivasertib (AZD5363) | CFN60088 | 1143532-39-1 | C21H25ClN6O2 = 428.92 | 5mg | QQ客服:215959384 |
| A66; A66 | CFN60089 | 1166227-08-2 | C17H23N5O2S2 = 393.53 | 5mg | QQ客服:1413575084 |
| NSC 23766; NSC 23766 | CFN60090 | 1177865-17-6 | C24H35N7.3HCl = 530.96 | 5mg | QQ客服:3257982914 |
| 他拉唑帕利; Talazoparib (BMN 673) | CFN60091 | 1207456-01-6 | C19H14F2N6O = 380.35 | 5mg | QQ客服:215959384 |
| 3-去氮腺嘌呤A盐酸盐; 3-Deazaneplanocin A (DZNeP) HCl | CFN60092 | 120964-45-6 | C12H14N4O3.HCl = 298.73 | 5mg | QQ客服:2056216494 |
| 瑞博西尼; Ribociclib (LEE011) | CFN60093 | 1211441-98-3 | C23H30N8O = 434.54 | 5mg | QQ客服:1457312923 |
| WZ4002; WZ4002 | CFN60094 | 1213269-23-8 | C25H27ClN6O3 = 494.18 | 5mg | QQ客服:215959384 |
| Alpelisib (BYL719); Alpelisib (BYL719) | CFN60095 | 1217486-61-7 | C19H22F3N5O2S = 441.47 | 5mg | QQ客服:2159513211 |
| Dorsomorphin dihydrochloride; Dorsomorphin dihydrochloride | CFN60096 | 1219168-18-9 | C24H25N5O.2HCl = 472.41 | 5mg | QQ客服:2159513211 |
| 盐酸吉西他滨; Gemcitabine HCl | CFN60097 | 122111-03-9 | C9H11F2N3O4.HCI = 299.66 | 20mg | QQ客服:215959384 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)